Peter E Lobie Selected Research

Peter E Lobie Research Topics

Disease

63	Breast Neoplasms (Breast Cancer) 02/2024 - 07/2002
63	Neoplasms (Cancer) 01/2024 - 10/2006
40	Carcinoma (Carcinomatosis) 11/2023 - 07/2002
21	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2011
9	Endometrial Neoplasms (Endometrial Cancer) 09/2017 - 08/2008
8	Hepatocellular Carcinoma (Hepatoma) 07/2017 - 07/2011
5	Triple Negative Breast Neoplasms 01/2024 - 01/2015
4	Disease Progression 09/2022 - 06/2014
4	Carcinogenesis 01/2021 - 08/2015
4	Lymphatic Metastasis 01/2019 - 10/2011
2	Adenocarcinoma 02/2024 - 05/2015
2	Ovarian Epithelial Carcinoma 02/2022 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 12/2020
2	Adenocarcinoma of Lung 11/2019 - 05/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2019 - 05/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 05/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2023

Drug/Important Bio-Agent (IBA)

20	Estrogen ReceptorsIBA 11/2023 - 12/2010
18	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2002
18	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2024 - 07/2002
13	MicroRNAs (MicroRNA)IBA 11/2022 - 07/2011
13	Trefoil Factor-3IBA 09/2022 - 12/2010
12	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2011
11	Tamoxifen FDA LinkGeneric 11/2023 - 12/2010
11	Messenger RNA (mRNA)IBA 01/2021 - 01/2007
9	Estrogens (Estrogen)FDA Link 01/2023 - 12/2010
8	LigandsIBA 01/2022 - 06/2010
8	Small Interfering RNA (siRNA)IBA 05/2015 - 06/2005
6	Growth Hormone (Somatotropin)IBA 01/2024 - 10/2006
5	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 02/2003
5	Long Noncoding RNAIBA 02/2024 - 12/2017
5	Phosphotransferases (Kinase)IBA 01/2024 - 05/2005
5	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2023 - 07/2011
5	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021 - 06/2010
5	Hormones (Hormone)IBA 01/2018 - 10/2006
5	Cadherins (E-Cadherin)IBA 05/2016 - 03/2006
4	ProlactinIBA 01/2017 - 10/2011
4	Transcription Factors (Transcription Factor)IBA 08/2015 - 06/2013
3	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2022 - 01/2011
3	4-nitrophenethyl bromide (NPB)IBA 10/2021 - 10/2018
3	Epidermal Growth Factor (EGF)IBA 06/2013 - 10/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 03/2009
3	Fibronectins (Fibronectin)IBA 01/2012 - 10/2004
2	Tyrosine (L-Tyrosine)FDA Link 01/2024 - 08/2015
2	AntioxidantsIBA 01/2024 - 05/2005
2	imidazopyridineIBA 12/2023 - 01/2023
2	PyrimidinesIBA 10/2023 - 01/2018
2	pyrimidineIBA 10/2023 - 04/2023
2	NF-kappa B (NF-kB)IBA 10/2023 - 05/2016
2	ThiouracilIBA 07/2023 - 04/2022
2	TriazolesIBA 07/2023 - 06/2023
2	OxadiazolesIBA 06/2023 - 01/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2023 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 11/2007
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 01/2015
2	RNA IsoformsIBA 11/2022 - 01/2017
2	Protein Isoforms (Isoforms)IBA 11/2022 - 09/2010
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 12/2010
2	PlatinumIBA 01/2022 - 12/2020
2	Estrogen Receptor alphaIBA 01/2022 - 01/2018
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2017
2	3' Untranslated Regions (3' UTR)IBA 01/2021 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 12/2019
2	Caspase 3 (Caspase-3)IBA 10/2018 - 12/2014
2	ClaudinsIBA 11/2017 - 01/2011
2	Phenobarbital (Luminal)FDA Link 10/2017 - 09/2017
2	Trastuzumab (Herceptin)FDA Link 09/2017 - 06/2014
2	matrigelIBA 06/2017 - 01/2012
2	azaspiraneIBA 09/2016 - 12/2014
2	AgarIBA 08/2015 - 02/2003
2	Complementary DNA (cDNA)IBA 05/2015 - 06/2014
2	Janus KinasesIBA 12/2014 - 01/2005
2	Prolactin Receptors (Prolactin Receptor)IBA 12/2012 - 04/2011
2	VimentinIBA 01/2012 - 10/2004
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2024
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2024
1	Antineoplastic Agents (Antineoplastics)IBA 01/2024
1	HydrazonesIBA 01/2024
1	tyrosine receptor (receptor, tyrosine)IBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Docetaxel (Taxotere)FDA Link 12/2023
1	taxaneIBA 11/2023
1	PiperazineIBA 10/2023
1	Histone Deacetylase InhibitorsIBA 07/2023
1	IsoxazolesIBA 07/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2023
1	Sulfhydryl Compounds (Thiols)IBA 06/2023
1	coumarinIBA 04/2023
1	human ERBB2 proteinIBA 04/2023
1	EnzymesIBA 01/2023
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2023

Therapy/Procedure

22	Therapeutics 02/2024 - 01/2011
7	Drug Therapy (Chemotherapy) 05/2023 - 08/2011
4	Precision Medicine 02/2022 - 12/2020
1	Immunotherapy 01/2024